Sequence 6 from Patent US 8076284

General Information


DRACP ID  DRACP01587

Peptide Name   Sequence 6 from Patent US 8076284

Sequence  FLXWLFKWAXK

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic construct

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  X=Xaa

Chiral  L



Physicochemical Information


Formula  C67H87N13O8

Absent amino acids  CDEGHIMNPQRSTVY

Common amino acids  FKLWX

Mass  160106

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  7

Net charge  2

Boman Index  1117

Hydrophobicity  49.09

Aliphatic Index  80

Half Life 
  /

Extinction Coefficient cystines  11000

Absorbance 280nm  1100

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 8076284 B2

Patent Title  Analogues of antimicrobial and anticancer peptide synthesized and produced from Gaegurin 5.

Other Iinformation  Granted Patent Family: 9s / 9ex; Family Jurisdictions: EP, KR, US, WO, JP, CN; Legal Status: Active; Application No: 30102807; Filed:May 14, 2007; Published: Dec 13, 2011; Earliest Priority: May 16, 2006; Granted: Dec 13, 2011

Other Published ID  CN101443352A  EP2016094A1  EP2016094A4  US20100105626  WO2007133033A1 




DRACP is developed by Dr.Zheng's team.